They work, so why stop using them?:

“I shudder at the thought of a government panel assigning a value to a day of a person’s life,” [Senator David] Vitter said in the news release. “It is sickening to think that care would be withheld from a patient simply because their life is not deemed valuable enough. I fear this is the beginning of a slippery slope leading to more and more rationing under the government takeover of health care that is being forced on the American people.”

The peril he speaks of? A 12-1 vote by an FDA advisory committee recommending that the breast cancer drug Avastin be denied because its side effects were deemed more harmful than its benefits. So the FDA is the new death panel.

We want to hear what you think about this article. Submit a letter to the editor or write to letters@theatlantic.com.